Exelixis (EXEL) insider trading in the last 6 months
3 insiders sold $5.5M. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Who files at Exelixis
Questions about EXEL's insider trades
Are EXEL insiders buying or selling?
3 insiders sold $5.5M across 3 filings in the last 6 months. No open-market buys on record. The newest filing: Dana Aftab, EVP, Research and Development, sold $2.2M on May 26, 2026.
Who are EXEL's biggest insider sellers?
By the dollars of their sales in the last 6 months: Dana Aftab (EVP, Research and Development), 1 sale; Christopher J. Senner (EVP and CFO), 1 sale; Patrick J. Haley (EVP, Commercial), 1 sale.
When did an EXEL insider last buy?
No EXEL insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Dana Aftab on May 26, 2026.
Exelixis's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.